Antibody–Drug Conjugate: A New Strategy to Block HIV-1 Entry (IMAGE)

Institute of Science Tokyo

Antibody–Drug Conjugate: A New Strategy to Block HIV-1 Entry

Caption

Researchers use new antibody–drug conjugates that combine a CD4 mimic with neutralizing antibodies to inhibit human immunodeficiency virus (HIV) entry into host cells.

Credit

Institute of Science Tokyo

Usage Restrictions

For use in scientific news only. Attribution is required. The image may not be modified in ways that alter its meaning or context.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.